Daniel S Donovan
Overview
Explore the profile of Daniel S Donovan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
97
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Donovan D, Podolnick J, Reizner W, Barron O, Catalano 3rd L, Glickel S
Hand (N Y)
. 2018 Jun;
14(6):797-802.
PMID: 29871493
A cadaveric study was performed to evaluate the accuracy and reliability of radiographic estimation of the volar lip fragment size in proximal interphalangeal joint fracture-dislocations. Middle phalangeal base volar lip...
2.
Podolnick J, Donovan D, Atanda Jr A
J Orthop Trauma
. 2017 May;
31(9):e281-e287.
PMID: 28471915
Objective: Determine the incidence of the delayed diagnosis of orthopaedic injuries in pediatric trauma patients. Design: Cross-sectional retrospective analysis. Setting: Level I pediatric trauma center. Patients/participants: All patients with an...
3.
Millar J, Lassman M, Thomas T, Ramakrishnan R, Jumes P, Dunbar R, et al.
J Lipid Res
. 2017 Mar;
58(6):1214-1220.
PMID: 28314859
Cholesteryl ester transfer protein (CETP) mediates the transfer of HDL cholesteryl esters for triglyceride (TG) in VLDL/LDL. CETP inhibition, with anacetrapib, increases HDL-cholesterol, reduces LDL-cholesterol, and lowers TG levels. This...
4.
Podolnick J, Donovan D, DeBellis N, Pino A
Clin Orthop Relat Res
. 2016 Nov;
475(5):1463-1469.
PMID: 27796800
Background: Lisfranc (tarsometatarsal joint) injuries are relatively rare, accounting for less than 1% of all fractures, and as many as 20% of subtle Lisfranc injuries are missed at the initial...
5.
Leung V, Chiu Y, Kotler D, Albu J, Zhu Y, Ham K, et al.
HIV Clin Trials
. 2016 Apr;
17(2):55-62.
PMID: 27077672
Background/objective: In a previous report of HIV-infected patients with fat redistribution, we found that recombinant human growth hormone (rhGH) therapy reduced visceral adipose tissue (VAT) but increased insulin resistance, and...
6.
Millar J, Reyes-Soffer G, Jumes P, Dunbar R, deGoma E, Baer A, et al.
J Clin Invest
. 2016 Apr;
126(4):1603-4.
PMID: 27035815
No abstract available.
7.
Reyes-Soffer G, Millar J, Ngai C, Jumes P, Coromilas E, Asztalos B, et al.
Arterioscler Thromb Vasc Biol
. 2016 Mar;
36(5):994-1002.
PMID: 26966279
Objective: Anacetrapib (ANA), an inhibitor of cholesteryl ester transfer protein (CETP) activity, increases plasma concentrations of high-density lipoprotein cholesterol (HDL-C), apolipoprotein A-I (apoA)-I, apoA-II, and CETP. The mechanisms responsible for...
8.
Nover A, Jones B, Yu W, Donovan D, Podolnick J, Cook J, et al.
J Biomech
. 2016 Feb;
49(5):668-677.
PMID: 26895780
Engineering of large articular cartilage tissue constructs remains a challenge as tissue growth is limited by nutrient diffusion. Here, a novel strategy is investigated, generating large constructs through the assembly...
9.
Reyes-Soffer G, Moon B, Hernandez-Ono A, Dionizovik-Dimanovski M, Dionizovick-Dimanovski M, Jimenez J, et al.
Sci Transl Med
. 2016 Jan;
8(323):323ra12.
PMID: 26819195
Mipomersen is a 20mer antisense oligonucleotide (ASO) that inhibits apolipoprotein B (apoB) synthesis; its low-density lipoprotein (LDL)-lowering effects should therefore result from reduced secretion of very-low-density lipoprotein (VLDL). We enrolled...
10.
Millar J, Reyes-Soffer G, Jumes P, Dunbar R, deGoma E, Baer A, et al.
J Clin Invest
. 2015 May;
125(6):2510-22.
PMID: 25961461
Background: Individuals treated with the cholesteryl ester transfer protein (CETP) inhibitor anacetrapib exhibit a reduction in both LDL cholesterol and apolipoprotein B (ApoB) in response to monotherapy or combination therapy...